Indian pharma majors to hit US growth bump in FY23
The revenue growth of about 16 leading Indian pharmaceutical companies is estimated to moderate to 6-7% in FY23, says ICRA.
pharma
July 2022
June 2022
May 2022
March 2022
January 2022
Dolo-650 maker doled out freebies worth ₹1,000 cr to doctors: I-T Dept
The Income Tax Department carried out search and seizure operations on the Bengaluru-based pharmaceutical group on July 6.
Marksans Pharma surges 18% on share buyback plan
The board of Marksans Pharma will meet on July 8 to consider a share buyback proposal.
Dr Reddy's rises 2% on deal to acquire Eton Pharma’s portfolio
Dr. Reddy's has acquired a portfolio of injectable products from Eton Pharma for an upfront payment of $5 million in cash, plus contingent payments of up to $45 million
Lawsuit settlements drag Sun Pharma into ₹2,227 cr loss in Q4
Sun Pharma incurred an exceptional loss of ₹3,936 crore on account of settlements, provisions related to Taro Pharmaceuticals, Ranbaxy.
EU drug regulator suspends 100 medicines due to faulty data from Indian CRO
To lift the suspension, companies relying on data from Indian CRO Synchron Research Services must provide alternative data demonstrating bioequivalence.
Torrent Pharma acquires 4 brands from Dr Reddy’s Lab
Torrent Pharma will acquire Styptovit-E, Finast, Finast-T, and Dynapress brands from Dr Reddy’s Laboratories.
Natco Pharma shares jump 9% in early trade; here’s why
Natco Pharma shares surged after the drug maker unveiled the first generic version of oral cancer drug Revlimid in the U.S. market.
Predictions 2022: Year of personalisation of healthcare and therapies
2022 will be the year of incubation for technological advancements that will shape the personalisation of healthcare and therapies for the next five decades.
Despite Covid, pharma growth halves to 6% in Q2 FY22; here's why
ICRA says pharmaceutical industry will grow between 7-9% in FY22, driven by domestic and emerging markets in the next few quarters.
